This job is closed
Applications are no longer available for this announcement. Explore current related opportunities below.
Job description
1 day ago Be among the first 25 applicants
Direct message the job poster from Hartmann Young
Biotech’s Leading Talent Partner | 73,000+ Connections
Chief Medical Officer - Solid Tumours
I’m partnered with a well-funded, venture-backed biotech developing next-generation ADC therapies for solid tumours, now seeking a CMO as it transitions toward the clinic in Q3 2025.
Backed by a $177M Series B, this is an opportunity to shape clinical strategy from IND through early development and help guide the company on a future path to IPO.
Key Highlights:
Progressing preclinical-stage oncology company with proprietary ADC platform
INDs planned for 6 solid tumour programs (Don't worry... not HER2 lol)
~36 FTEs, Bay Area HQ, hybrid model
Strong scientific and investor backing
Lean, collaborative culture with experienced leadership
Ideal Candidate:
MD or MD/PhD with oncology and IND experience
Background in ADCs or bispecifics preferred
Comfortable in small biotech/startup settings
Able to lead clinical strategy and represent the company externally
Small Biotech Experience needed
Highly collaborative mindset
DM me for more details or to refer someone confidentially.
Seniority level
Executive
Employment type
Full-time
Job function
Science, Research, and Strategy/Planning
Industries
Biotechnology Research and Pharmaceutical Manufacturing
Referrals increase your chances of interviewing at Hartmann Young by 2x
Sign in to set job alerts for “Chief Medical Officer” roles.
United States $250,000.00-$300,000.00 1 week ago
#J-18808-Ljbffr
Worksite address
san francisco, CA, 94199, US
Who can apply
Review the original listing for work authorization, qualifications and employer requirements.